Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368. Case and Commentary Aug 2022 When Experiencing Inequitable Health Care Is a Patient’s Norm, How Should Iatrogenic Harm Be Considered? Bantale Ayisire, MS, RN and Kristen R. Choi, PhD, RN Inequitable care and outcomes experienced by persons with mental illness have long been exacerbated by stigma expressed by clinicians. AMA J Ethics. 2022;24(8):E729-734. doi: 10.1001/amajethics.2022.729. Case and Commentary Mar 2022 Alignment of Abolition Medicine With Reproductive Justice Crystal M. Hayes, PhD, MSW and Anu Manchikanti Gomez, PhD Abolition medicine and reproductive justice are synergistic approaches that advance a radical vision of a racially just world. AMA J Ethics. 2022;24(3):E188-193. doi: 10.1001/amajethics.2022.188. Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508. Case and Commentary Jan 2017 Saving the Starfish: Physicians’ Roles in Responding to Human Rights Abuses in Global Health Practice Monir Moniruzzaman, PhD As a matter of medical ethics, physicians must advocate for their vulnerable patients and medical schools should offer training in advocacy and activism. AMA J Ethics. 2017;19(1):8-15. doi: 10.1001/journalofethics.2017.19.1.ecas1-1701. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368.
Case and Commentary Aug 2022 When Experiencing Inequitable Health Care Is a Patient’s Norm, How Should Iatrogenic Harm Be Considered? Bantale Ayisire, MS, RN and Kristen R. Choi, PhD, RN Inequitable care and outcomes experienced by persons with mental illness have long been exacerbated by stigma expressed by clinicians. AMA J Ethics. 2022;24(8):E729-734. doi: 10.1001/amajethics.2022.729.
Case and Commentary Mar 2022 Alignment of Abolition Medicine With Reproductive Justice Crystal M. Hayes, PhD, MSW and Anu Manchikanti Gomez, PhD Abolition medicine and reproductive justice are synergistic approaches that advance a radical vision of a racially just world. AMA J Ethics. 2022;24(3):E188-193. doi: 10.1001/amajethics.2022.188.
Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508.
Case and Commentary Jan 2017 Saving the Starfish: Physicians’ Roles in Responding to Human Rights Abuses in Global Health Practice Monir Moniruzzaman, PhD As a matter of medical ethics, physicians must advocate for their vulnerable patients and medical schools should offer training in advocacy and activism. AMA J Ethics. 2017;19(1):8-15. doi: 10.1001/journalofethics.2017.19.1.ecas1-1701.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.